Your browser doesn't support javascript.
loading
Risk assessment for hospital admission in patients with COPD; a multi-centre UK prospective observational study.
Fermont, Jilles M; Bolton, Charlotte E; Fisk, Marie; Mohan, Divya; Macnee, William; Cockcroft, John R; McEniery, Carmel; Fuld, Jonathan; Cheriyan, Joseph; Tal-Singer, Ruth; Wilkinson, Ian B; Wood, Angela M; Polkey, Michael I; Müllerova, Hana.
Afiliación
  • Fermont JM; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, England, United Kingdom.
  • Bolton CE; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England, United Kingdom.
  • Fisk M; Division of Respiratory Medicine and NIHR Nottingham BRC Respiratory Theme, School of Medicine, University of Nottingham, Nottingham, England, United Kingdom.
  • Mohan D; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, England, United Kingdom.
  • Macnee W; Medical Innovation, Value Evidence and Outcomes GSK, Collegeville, PA, United States.
  • Cockcroft JR; Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, Scotland, United Kingdom.
  • McEniery C; Department of Cardiology, Columbia University Medical Centre, New York, New York, United States.
  • Fuld J; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, England, United Kingdom.
  • Cheriyan J; Department of Respiratory Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, England, United Kingdom.
  • Tal-Singer R; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, England, United Kingdom.
  • Wilkinson IB; Medical Innovation, Value Evidence and Outcomes GSK, Collegeville, PA, United States.
  • Wood AM; Division of Experimental Medicine and Immunotherapeutics, Department of Medicine, University of Cambridge, Cambridge, England, United Kingdom.
  • Polkey MI; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, England, United Kingdom.
  • Müllerova H; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, England, United Kingdom.
PLoS One ; 15(2): e0228940, 2020.
Article en En | MEDLINE | ID: mdl-32040531
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Hospitalización Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad Pulmonar Obstructiva Crónica / Hospitalización Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Estados Unidos